Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News TCT 2025

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Yael L. Maxwell

November 04, 2025

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presenter: Byeong-Keuk Kim

October 25, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

Presentation TCT 2018

DAPT and Anticoagulation Post TAVR: What is the Standard of Care?

Presenter: Martina Kelly Speight, Patricia Keegan

September 23, 2018

Presentation TCT 2018

Considerations for LAA Closure Devices: FDA Perspective

Presenter: Andrew Farb

September 22, 2018

Presentation TCT 2018

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

Presenter: Akihide Konishi

September 22, 2018

Presentation TCT 2018

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Presenter: Marek Grygier

September 22, 2018

Presentation TCT 2018

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Presenter: Shephal Doshi

September 22, 2018

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

Presentation TCT 2017

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Presenter: Brij Maini, Petr Neuzil, Grzegorz Smolka, MD

October 31, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

Advertisement

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

What’s Going to Be Big at TCT 2024?

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

DAPT and Anticoagulation Post TAVR: What is the Standard of Care?

Considerations for LAA Closure Devices: FDA Perspective

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

The Overview of Clinical Trials and Current Target Population for LAAC Closure

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content